Agile regulations for advanced therapeutic products and clinical trials

From Health Canada

Current status: Open

Opened on July 18, 2019 and will close to new input on August 30, 2019.

The goal of this consultation is to seek feedback on what Health Canada should consider in developing new clinical trials regulations as well as implementing the pathway for Advanced Therapeutic Products. The department aims to continue the conversation with stakeholders and gather other ideas to help ensure our approach supports innovation while protecting the health and safety of Canadians.

Join in: how to participate

Send us an email:

Send an email to hc.hpfb.engagement-mobilisation.dgpsa.sc@canada.ca to request the consultation information document and questions by email.

Who is the focus of this consultation

Health Canada wants to hear from:

Key questions for discussion

Please send an email to hc.hpfb.engagement-mobilisation.dgpsa.sc@canada.ca to request the consultation information document and questions by email.

Related information

Contact us

Email: hc.hpfb.engagement-mobilisation.dgpsa.sc@canada.ca

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: